Sign in
4

Changes in Ownership

Artiva Biotherapeutics, Inc. Filed Acc 0001415889-24-020047

Director bought 8,333,333 shares at $12.00 ($99,999,996)

  • Director acquired 461,687 shares (other)
  • Director acquired 1,058,282 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

RA CAPITAL MANAGEMENT, L.P. · Director

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2024-07-22 Conversion : show line 1 in the form +725,391 725,391 I
2024-07-22 Conversion : show line 2 in the form +264,571 264,571 I
2024-07-22 Conversion : show line 3 in the form +68,320 68,320 I
2024-07-22 Other acquisition : show line 4 in the form +323,181 $10.20 $3,296,446 1,048,572 I
2024-07-22 Other acquisition : show line 5 in the form +138,506 $10.20 $1,412,761 138,506 I
2024-07-22 Purchase : show line 6 in the form +7,645,007 $12.00 $91,740,084 8,693,579 I
2024-07-22 Purchase : show line 7 in the form +688,326 $12.00 $8,259,912 826,832 I
Open-market purchases · 8,333,333 sh · avg $12.00 · $99,999,996

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2024-07-22 Conversion : show line 8 in the form Series A Preferred Stock −564,372 0 I
2024-07-22 Conversion : show line 9 in the form Series A Preferred Stock −210,898 0 I
2024-07-22 Conversion : show line 10 in the form Series A Preferred Stock −68,320 0 I
2024-07-22 Conversion : show line 11 in the form Series B Preferred Stock −161,019 0 I
2024-07-22 Conversion : show line 12 in the form Series B Preferred Stock −53,673 0 I
Loading xslF345X05/form4-07242024_080707.xml…